Abbott Laboratories 10-K for FY2024
Abbott Laboratories (ABT)
10-K
2025-02-21
For: 2024-12-31
View Original
Added on
April 11, 2026
About this 10-K
Abbott Laboratories filed this 10-K on February 21, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $41.95B
- up 4.6% from $40.11B a year earlier
- Net income
- $13.4B
- up 134.2% from net income of $5.72B a year earlier
- Diluted EPS
- $7.64
- up 134.4% from $3.26 a year earlier